291 related articles for article (PubMed ID: 23536675)
1. Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.
Dodd KA; McElroy AK; Jones ME; Nichol ST; Spiropoulou CF
J Virol; 2013 Jun; 87(11):6161-71. PubMed ID: 23536675
[TBL] [Abstract][Full Text] [Related]
2. Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40/CD40L Interactions for Prevention of Encephalitis.
Barbeau DJ; Cartwright HN; Harmon JR; Spengler JR; Spiropoulou CF; Sidney J; Sette A; McElroy AK
J Virol; 2021 Nov; 95(23):e0150621. PubMed ID: 34495703
[TBL] [Abstract][Full Text] [Related]
3. Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model.
Dodd KA; McElroy AK; Jones TL; Zaki SR; Nichol ST; Spiropoulou CF
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2874. PubMed ID: 24922480
[TBL] [Abstract][Full Text] [Related]
4. CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis.
Harmon JR; Spengler JR; Coleman-McCray JD; Nichol ST; Spiropoulou CF; McElroy AK
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258000
[TBL] [Abstract][Full Text] [Related]
5. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
[TBL] [Abstract][Full Text] [Related]
6. Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations.
Xu L; Paine AC; Barbeau DJ; Alencastro F; Duncan AW; McElroy AK
J Virol; 2023 Sep; 97(9):e0085323. PubMed ID: 37695055
[TBL] [Abstract][Full Text] [Related]
7. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
[TBL] [Abstract][Full Text] [Related]
8. The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion.
Bamia A; Marcato V; Boissière M; Mansuroglu Z; Tamietti C; Romani M; Simon D; Tian G; Niedergang F; Panthier JJ; Flamand M; Souès S; Bonnefoy E
J Virol; 2020 Dec; 95(1):. PubMed ID: 33087469
[TBL] [Abstract][Full Text] [Related]
9. Isotype-Specific Fc Effector Functions Enhance Antibody-Mediated Rift Valley Fever Virus Protection
Cartwright HN; Barbeau DJ; McElroy AK
mSphere; 2021 Oct; 6(5):e0055621. PubMed ID: 34494884
[TBL] [Abstract][Full Text] [Related]
10. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge.
Dodd KA; Bird BH; Metcalfe MG; Nichol ST; Albariño CG
J Virol; 2012 Apr; 86(8):4204-12. PubMed ID: 22345465
[TBL] [Abstract][Full Text] [Related]
11. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
[TBL] [Abstract][Full Text] [Related]
12. Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse.
Gray KK; Worthy MN; Juelich TL; Agar SL; Poussard A; Ragland D; Freiberg AN; Holbrook MR
PLoS Negl Trop Dis; 2012; 6(2):e1529. PubMed ID: 22389738
[TBL] [Abstract][Full Text] [Related]
13. Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.
Wonderlich ER; Caroline AL; McMillen CM; Walters AW; Reed DS; Barratt-Boyes SM; Hartman AL
J Virol; 2018 Feb; 92(3):. PubMed ID: 29118127
[TBL] [Abstract][Full Text] [Related]
14. The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus.
Fernandez JC; Billecocq A; Durand JP; Cêtre-Sossah C; Cardinale E; Marianneau P; Pépin M; Tordo N; Bouloy M
Clin Vaccine Immunol; 2012 Jan; 19(1):5-10. PubMed ID: 22072723
[TBL] [Abstract][Full Text] [Related]
15. Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.
Gowen BB; Bailey KW; Scharton D; Vest Z; Westover JB; Skirpstunas R; Ikegami T
Antiviral Res; 2013 May; 98(2):135-43. PubMed ID: 23523764
[TBL] [Abstract][Full Text] [Related]
16. Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection.
McElroy AK; Nichol ST
Virology; 2012 Jan; 422(1):6-12. PubMed ID: 22018491
[TBL] [Abstract][Full Text] [Related]
17. Development of monoclonal antibodies to Rift Valley Fever Virus and their application in antigen detection and indirect immunofluorescence.
Mroz C; Schmidt KM; Reiche S; Groschup MH; Eiden M
J Immunol Methods; 2018 Sep; 460():36-44. PubMed ID: 29894749
[TBL] [Abstract][Full Text] [Related]
18. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
Terasaki K; Tercero BR; Makino S
Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
[TBL] [Abstract][Full Text] [Related]
19. Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.
Indran SV; Lihoradova OA; Phoenix I; Lokugamage N; Kalveram B; Head JA; Tigabu B; Smith JK; Zhang L; Juelich TL; Gong B; Freiberg AN; Ikegami T
J Gen Virol; 2013 Jul; 94(Pt 7):1441-1450. PubMed ID: 23515022
[TBL] [Abstract][Full Text] [Related]
20. NSG-Mice Reveal the Importance of a Functional Innate and Adaptive Immune Response to Overcome RVFV Infection.
Michaely LM; Rissmann M; Keller M; König R; von Arnim F; Eiden M; Rohn K; Baumgärtner W; Groschup M; Ulrich R
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
